Wells Fargo’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Sell |
62,441
-5,336
| -8% | -$14.3K | ﹤0.01% | 4482 |
|
|
2025
Q1 | $95.6K | Buy |
67,777
+25,945
| +62% | +$36.6K | ﹤0.01% | 4671 |
|
|
2024
Q4 | $83.2K | Buy |
41,832
+11,834
| +39% | +$23.6K | ﹤0.01% | 4805 |
|
|
2024
Q3 | $94.5K | Buy |
29,998
+4,294
| +17% | +$13.5K | ﹤0.01% | 4655 |
|
|
2024
Q2 | $81.2K | Buy |
+25,704
| New | +$81.2K | ﹤0.01% | 4703 |
|
|
2022
Q4 | – | Sell |
-200
| Closed | -$1K | – | 7103 |
|
|
2022
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 5919 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 5983 |
|
|
2022
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 6208 |
|
|
2021
Q4 | $4K | Sell |
200
-333
| -62% | -$6.66K | ﹤0.01% | 6176 |
|
|
2021
Q3 | $14K | Sell |
533
-267
| -33% | -$7.01K | ﹤0.01% | 5756 |
|
|
2021
Q2 | $19K | Sell |
800
-1,400
| -64% | -$33.3K | ﹤0.01% | 5585 |
|
|
2021
Q1 | $54K | Buy |
+2,200
| New | +$54K | ﹤0.01% | 5425 |
|